Dr. Robert F. Melendez, MD

Dr. Melendez practices at Juliette Eye Surgery Center in Albuquerque, New Mexico.

Dr. Melendez's NPI, 1316932742, was assigned on September 12, 2005. Dr. Melendez graduated from University of New Mexico School of Medicine in 2000. Dr. Melendez holds New Mexico license MD2004-0086.

Dr. Melendez's primary practice is Juliette Eye Surgery Center, at 6401 Holly NE Ave, Albuquerque, NM 87113 in Bernalillo County. The practice phone is (505) 355-2020.

Dr. Melendez's primary practice is Juliette Eye Surgery Center in Albuquerque, New Mexico. Dmand AI also links Dr. Melendez to 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melendez practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Melendez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Melendez is licensed in New Mexico.

CMS data shows 2,555 Medicare services from Dr. Melendez across 15 procedure codes in 2024, for 545 Medicare patients. Medicare paid $250,410 for them.

CMS counts 545 Medicare patients who saw Dr. Melendez in 2024. The largest group is 65 to 74, with 306 patients. 63% of them have high cholesterol, and 59% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Melendez's median patient age at 72, with 61% women.

In 2024, Dr. Melendez wrote 265 Medicare Part D claims for 113 patients. 38% of them were for generic drugs. CMS names the drug for 201 of them, across 8 drugs with 11 or more claims each, at $81,971 in total drug cost. In 2023, CMS named 207 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Melendez for performance year 2024, reported individually. Dr. Melendez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 230 procedures of cataract surgery by Dr. Melendez, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Melendez, published from 2022 to 2025. Dr. Melendez has published most often in Clin Ophthalmol.

CMS Open Payments shows 660 general payments to Dr. Melendez from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Alcon Laboratories Inc paid the most, $262,708.

Dr. Melendez graduated from University of New Mexico School of Medicine in 2000.